TP53 and thyroid cancer: The study results suggest that gene fusions represent a dominant mechanism of pediatric thyroid cancer and that pathogenic variants (including BRAF/RAS and high-risk TP53/TERT) are rare in this age group.DICER1 variants were identified in malignant (8%) and benign (13%) nodules.